Cirqle Biomedical is developing a hormone-free contraceptive that reinforces the natural cervical mucus barrier to create a temporary barrier against sperm penetration. This approach addresses the need for effective birth control options that minimize the physical and mental side effects associated with traditional hormonal contraceptives.
Funding
$2.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many women experience physical and mental side effects from hormonal contraceptives, yet a new mechanism of action in contraception has not been developed in over 60 years. This lack of innovation limits women's reproductive choices and overall quality of life.
Solution
Cirqle Biomedical is developing a hormone-free, on-demand contraceptive that reinforces the natural cervical mucus barrier. The technology uses a molecule that interacts with cervical mucus to temporarily prevent sperm penetration. This localized approach aims to provide effective birth control without the systemic side effects associated with hormonal methods. The technology is currently in pre-clinical development.
Target Audience
The primary target audience is women seeking hormone-free contraceptive options with fewer side effects.
Features
- Reinforces the natural cervical mucus barrier
- Designed to be hormone-free
- Provides on-demand contraception
- Localized action minimizes systemic exposure